banter and General Discussion, page-10584

Thanks @Phaedrus

I have been following MSB very closely and have listen to this too. I was there in person at the last AGM.
This being a BioTech industry and lots to learn for me here, I also follow closely the top contributors tot his forum (yourself included ofcourse).

I am with OP here with 600k figure. and also that it can change with time.
On Wahoo, ET is probably the only guy I go to read and so, I pasted those questions as to connect to the dots and see what OP has to say about it.
More info is never bad, just like your message above re-affirming the pricing. Thanks for that.

I am quite deep into it and still waiting on the sidelines to dip for more.
I think the SP is definitely ridiculous at these levels but having been burnt coupel of time in the last few years, I want to be super careful (like many others I am sure).
The only concern I have at the moment is the talks about upcoming Capital Raise around end of this year unless early approval.
as well as the rising shorts at these SP levels.

I have picked ET's brains on CR but he keeps talking about the suggested CR method rather than chances of CR happening by late this year.

It's hard for me to digest that after such a hefty CR late last year and then FDA feedback within a month about the sufficient data and BLA submission as well as the ommision of Adult trial requirement pre-BLA, they would do another CR pre-approval.
I just don't understand why would they manage funds like this.

Do you have any thoughts on this please? chances of another CR before January 7th of 2025?

I am waiting on the sidelines with more funds just becuase of this uncertainty.

Thanks once again, as always.